British American Tobacco’s U.S.-listed ADRs are trading lower as the market refocuses on tobacco litigation exposure in Canada and the potential earnings and cash-flow impact of a large provision. The renewed pressure follows disclosure of a £6.2 billion provision related to Canadian lawsuit settlements and commentary pointing to ongoing regulatory and fiscal headwinds that could weigh on performance.

A multi-billion-pound provision can reshape near-term profit optics and influence investor expectations around leverage, capital returns, and flexibility to invest in next-generation products. With tobacco equities often owned for income, any perceived risk to dividend coverage or buyback capacity can quickly translate into price weakness even if underlying cash generation remains resilient.

Investors will be watching for clearer milestones on court approvals, the structure and timing of payments, and whether any counterparties challenge the settlement framework. Separately, traders will monitor additional regulatory/tax actions in major markets and how management frames 2026 execution, including any updated guidance, capital-allocation priorities, and progress in smokeless categories.